Glowing medical syringe for injection

(© Delya - stock.adobe.com)

In A Nutshell

  • Tiny glow-in-the-dark particles injected into the bloodstream light up on command when a focused sound beam is aimed at them from outside the body, no surgery or implants required.
  • Combined with optogenetics, a technique that uses light to switch specific brain cells on or off, the system holds potential for conditions like Parkinson’s disease and chronic pain.
  • In freely moving mice, steering the sound beam to the left or right side of the brain caused the animals to circle in the corresponding direction, demonstrating real-time behavioral control.
  • Short-term safety results in mice were largely reassuring, but human trials remain years away and will require extensive additional testing.

Scientists at Stanford University and the University of Virginia have developed glow-in-the-dark nanoparticles that circulate through the bloodstream and light up on command, triggered by a beam of sound aimed from outside the body. No brain surgery or implanted hardware necessary. Just an injection and a directed pulse of ultrasound that makes the particles glow wherever the beam is pointed, whether that’s the brain, the spinal cord, or anywhere else the blood flows.

Making something glow inside the body is interesting enough on its own. The real payoff comes from pairing those particles with optogenetics, one of neuroscience’s most powerful tools. Optogenetics uses precisely timed pulses of light to switch specific neurons on or off, and it has been used to map how the brain drives movement, encodes memory, and generates emotion, with genuine promise for conditions like Parkinson’s disease and chronic pain. Getting that light reliably into the brain, though, has been the stubborn problem. Light fades within a few millimeters of tissue, leaving researchers no choice but to implant fiber optic cables directly into the brain, an invasive procedure that locks the device in one spot.

Published in Nature Materials, the new approach replaces that fixed implant with something that flows. Researchers injected mice with particles called mechanoluminescent nanotransducers, or MLNTs, a shorthand for tiny particles engineered to glow when struck by sound waves. Once in the bloodstream, they circulated widely through the body’s vascular network. Wherever a focused ultrasound beam was aimed, the particles there lit up. Move the beam, and the light moved with it. No implant, no surgery, no fixed position.

How Glow-in-the-Dark Nanoparticles Power Non-Invasive Brain Stimulation

Ultrasound works here because it can penetrate deep tissue and, at the controlled levels used in this study, is generally considered safe, while also being aimed with precision. By adjusting the frequency and depth of the beam, researchers controlled where the light appeared and how large each glowing spot was. In lab gels that simulate living tissue, the beam produced spots as small as 0.18 millimeters, roughly the width of two human hairs. In live mice, that translated to distinct, confined spots across three separate areas of the brain’s cortex, with minimal spread between them. Even the skull posed little barrier, and light from the nanoparticles was able to reach nearby brain tissue from the bloodstream.

Proving the light was doing biological work required mice engineered to carry light-sensitive proteins in specific brain cells. When the beam was active and MLNTs were circulating, those cells fired at close to a 100 percent response rate in the recorded neurons. Remove either the particles or the sound, and the neurons went quiet. Tissue staining of the brain afterward confirmed that activation was confined to the exact region the beam had targeted, with no meaningful spread to neighboring areas. Separate tests verified the ultrasound beam wasn’t triggering the neurons directly, isolating the nanoparticles’ light as the actual mechanism.

Profile of a woman with glowing brain illustration on a sunny background
Scientists used sound waves to activate glow-in-the-dark nanoparticles in the bloodstream, stimulating brain cells without surgery. (© Татьяна Макарова – stock.adobe.com)

Non-Invasive Brain Stimulation Controls Mouse Behavior in Real Time

Freely moving animals provided the clearest look at what the system could do in practice. Researchers attached a wearable ultrasound transducer, light enough to weigh barely a gram, to each mouse’s head, then gave the animals an injection of MLNTs. To keep the particles active, researchers also periodically shone UV light onto the animals’ backs to recharge them. Steering the beam toward the left side of the striatum, a brain region central to movement, caused the mice to circle left. Switch to the right, and they circled right. Two genetically distinct groups of neurons in the striatum, known to produce opposing movement tendencies, each triggered the expected opposite behavior when activated, and switching between them mid-experiment reversed the circling on cue.

Safety results in the short term were largely reassuring. Mice cleared the nanoparticles from their bodies through urine and feces within about a week. Brain temperature barely budged during stimulation, rising less than one degree Celsius above normal. Blood tests at one and four weeks showed counts within normal ranges overall, though researchers noted a mild difference in white blood cell levels compared to controls and flagged it for continued monitoring. Brain tissue from both time points showed no inflammation, cell loss, or structural damage, and neuron density was unchanged between treated animals and controls.

Beyond the Brain: Non-Invasive Therapy Anywhere the Blood Flows

Because the particles travel everywhere the blood goes, the technique doesn’t stop at the brain. Researchers also triggered glowing in the spinal cord, gut, and limbs in the same mice, using the same injection and a repositioned beam, reaching areas that implant-based approaches routinely struggle to access. Those results point to a range of potential applications the team identified: photodynamic cancer therapy, light-triggered drug delivery, and gene editing, all of which depend on getting light to a precise location inside the body without open surgery.

Ultrasound is already a daily clinical tool, and these particles appear to clear the body on their own within about a week. Human trials remain years away, with more safety work needed before this platform could move toward patients. In mice, though, the principle holds: aim a beam of sound, and light appears on demand, wherever the blood flows, from outside the body, without a single cut.


Disclaimer: This article is based on research conducted in mice and has not been tested in humans. Findings from animal studies do not always translate to human outcomes. Nothing in this article should be interpreted as medical advice or an endorsement of any treatment or therapy.


Paper Notes

Study Limitations

All experiments were conducted in mice, and the path to human application remains long. Ultrasound attenuation increases with tissue depth and body size, meaning the pressures used in mice may need to be calibrated upward for larger animals or people. In freely behaving animals, the MLNT nanoparticles required periodic recharging via ultraviolet light applied to the skin, a step that would need practical adaptation for any clinical setting. Researchers also noted a modest increase in white blood cell counts following injection, an immune signal they flagged for further investigation. Spatial resolution of the light source depends on the properties of both the ultrasound beam and the vascular architecture of the target tissue, which varies across organs and individuals, adding variability that future work will need to address.

Funding and Disclosures

Guosong Hong received support from three NIH awards (5R00AG056636-04, 1R34NS127103-01, and R01NS126076-01), an NSF CAREER Award (2045120), an NSF EAGER Award (2217582), a Rita Allen Foundation Scholars Award, a Beckman Technology Development Grant, a grant from the Focused Ultrasound Foundation, gifts from the Spinal Muscular Atrophy Foundation and the Pinetops Foundation, two seed grants from the Wu Tsai Neurosciences Institute, two seed grants from the Bio-X Initiative of Stanford University, and a Synthetic Neurobiology Grant of Stanford University. Harald Sontheimer received four NIH awards (R01AG072430, R56 AG077720, R01AG085359, and R01NS123069). Shan Jiang was supported by the BRAIN Postdoctoral Fellowship from the University of Virginia. Marigold G. Malinao and Nicholas J. Rommelfanger received Bio-X Graduate Student Fellowships and NSF Graduate Research Fellowships Program support (award 1656518). Xiang Wu received a Stanford Graduate Fellowship. Xiaoke Chen received four NIH awards (R01NS129834, R01DA059602, R01MH116904, and R01DA045664). Authors declare no competing interests.

Publication Details

Shan Jiang, Marigold G. Malinao, Fan Yang, Yushun Zeng, Silky S. Hou, Xiang Wu, Nicholas J. Rommelfanger, Lata Chaunsali, Su Zhao, Han Cui, Jun Ding, Xiaoke Chen, Qifa Zhou, Harald Sontheimer, and Guosong Hong authored the study, which was published April 13, 2026, in Nature Materials under the title “An ultrasound-scanning in vivo light source.” DOI: https://doi.org/10.1038/s41563-026-02556-z. Correspondence may be addressed to Guosong Hong at Stanford University ([email protected]).

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment